CASP6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.174800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.487600E-01
Normal-vs-Stage2
8.829800E-01
Normal-vs-Stage3
7.778200E-01
Normal-vs-Stage4
6.054400E-01
Stage1-vs-Stage2
7.963000E-01
Stage1-vs-Stage3
9.182600E-01
Stage1-vs-Stage4
4.125400E-01
Stage2-vs-Stage3
6.899600E-01
Stage2-vs-Stage4
4.720400E-01
Stage3-vs-Stage4
4.184400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.637200E-01
Normal-vs-AfricanAmerican
9.160400E-01
Normal-vs-Asian
6.322800E-01
Caucasian-vs-AfricanAmerican
5.607800E-01
Caucasian-vs-Asian
9.975600E-02
AfricanAmerican-vs-Asian
5.633600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.630600E-01
Normal-vs-Female
8.904400E-01
Male-vs-Female
5.083600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.098600E-01
Normal-vs-Age(41-60Yrs)
9.219800E-01
Normal-vs-Age(61-80Yrs)
7.654800E-01
Normal-vs-Age(81-100Yrs)
9.802000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.949000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.654600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.150800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.457400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.924600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.931400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.752800E-01
Normal-vs-Daily Drinker
7.889000E-01
Normal-vs-Weekly Drinker
5.696000E-01
Normal-vs-Occasional Drinker
9.183000E-01
Normal-vs-Social Drinker
7.288600E-01
Non Drinker-vs-Daily Drinker
5.586400E-01
Non Drinker-vs-Weekly Drinker
3.053200E-01
Non Drinker-vs-Occasional Drinker
7.643000E-01
Non Drinker-vs-Social Drinker
5.055200E-01
Daily Drinker-vs-Weekly Drinker
7.027400E-01
Daily Drinker-vs-Occasional Drinker
4.707000E-01
Daily Drinker-vs-Social Drinker
9.304400E-01
Weekly Drinker-vs-Occasional Drinker
2.814600E-01
Weekly Drinker-vs-Social Drinker
7.586000E-01
Occasional Drinker-vs-Social Drinker
4.350000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.182200E-01
Normal-vs-Grade 2
3.767800E-02
Normal-vs-Grade 3
2.684000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.037900E-02
Grade 1-vs-Grade 3
4.106100E-02
Grade 1-vs-Grade 4
2.182200E-01
Grade 2-vs-Grade 3
8.675600E-01
Grade 2-vs-Grade 4
3.767800E-02
Grade 3-vs-Grade 4
2.684000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.653000E-01
Normal-vs-NonDiabetic
8.928200E-01
Diabetic-vs-NonDiabetic
2.585800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.174400E-01
Normal-vs-NoPancreatitis
7.940400E-01
Pancreatitis-vs-NoPancreatitis
2.390200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.086400E-01
Normal-vs-N1
9.223200E-01
N0-vs-N1
3.162200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.048600E-01
Normal-vs-TP53-NonMutant
8.500200E-01
TP53-Mutant-vs-TP53-NonMutant
1.199680E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
